528 related articles for article (PubMed ID: 18936106)
21. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation.
Barmeyer C; Harren M; Schmitz H; Heinzel-Pleines U; Mankertz J; Seidler U; Horak I; Wiedenmann B; Fromm M; Schulzke JD
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G244-52. PubMed ID: 14715519
[TBL] [Abstract][Full Text] [Related]
23. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
Amasheh M; Grotjohann I; Amasheh S; Fromm A; Söderholm JD; Zeitz M; Fromm M; Schulzke JD
Scand J Gastroenterol; 2009; 44(10):1226-35. PubMed ID: 19658020
[TBL] [Abstract][Full Text] [Related]
24. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells.
Nava P; López S; Arias CF; Islas S; González-Mariscal L
J Cell Sci; 2004 Nov; 117(Pt 23):5509-19. PubMed ID: 15494377
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
[TBL] [Abstract][Full Text] [Related]
26. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.
Duizer E; Gilde AJ; Versantvoort CH; Groten JP
Toxicol Appl Pharmacol; 1999 Mar; 155(2):117-26. PubMed ID: 10053166
[TBL] [Abstract][Full Text] [Related]
27. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
[TBL] [Abstract][Full Text] [Related]
28. The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers.
McGilligan VE; Wallace JM; Heavey PM; Ridley DL; Rowland IR
Food Chem Toxicol; 2007 Sep; 45(9):1593-8. PubMed ID: 17399881
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
[TBL] [Abstract][Full Text] [Related]
30. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
31. Tight junctions and cell-cell interactions.
Utech M; Brüwer M; Nusrat A
Methods Mol Biol; 2006; 341():185-95. PubMed ID: 16799199
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis and functional changes of dipeptide transporter (PepT1) in the rat small intestine after traumatic brain injury.
Hang CH; Shi JX; Sun BW; Li JS
J Surg Res; 2007 Jan; 137(1):53-60. PubMed ID: 17081567
[TBL] [Abstract][Full Text] [Related]
33. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
34. ClC-2 regulates mucosal barrier function associated with structural changes to the villus and epithelial tight junction.
Nighot PK; Blikslager AT
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G449-56. PubMed ID: 20489043
[TBL] [Abstract][Full Text] [Related]
35. Antiflagellin antibodies recognize the autoantigens Toll-Like Receptor 5 and Pals 1-associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn's disease.
Lunardi C; Bason C; Dolcino M; Navone R; Simone R; Saverino D; Frulloni L; Tinazzi E; Peterlana D; Corrocher R; Puccetti A
J Intern Med; 2009 Feb; 265(2):250-65. PubMed ID: 18796002
[TBL] [Abstract][Full Text] [Related]
36. Changes in the expression of claudins in active ulcerative colitis.
Oshima T; Miwa H; Joh T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S146-50. PubMed ID: 19120888
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells.
Kimura K; Teranishi S; Nishida T
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):597-603. PubMed ID: 19171646
[TBL] [Abstract][Full Text] [Related]
38. Cell wall fraction of Enterococcus hirae ameliorates TNF-alpha-induced barrier impairment in the human epithelial tight junction.
Miyauchi E; Morita H; Okuda J; Sashihara T; Shimizu M; Tanabe S
Lett Appl Microbiol; 2008 Apr; 46(4):469-76. PubMed ID: 18298454
[TBL] [Abstract][Full Text] [Related]
39. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
40. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
Mankertz J; Schulzke JD
Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
